A Decision Support System for preclinical assessment of nanomaterials in medical products: the REFINE DSS.

ABSTRACT: The application of nanomaterials in medicine has led to novel pharmaceuticals and medical devices that have demonstrated a strong potential for increasing the efficacy/performance and safety of therapeutic and diagnostic procedures to address a wide range of diseases. However, the successful translation of these technologies from their inception (proof-of-concept) to clinical practice has been challenged by substantial gaps in the scientific and technical capacity of R&D companies, especially SMEs, to keep up with the ever-evolving regulatory expectations in the emerging area of nanomedicine. To address these challenges, the EU Horizon 2020 project REFINE has developed a Decision Support System (DSS) to support developers of nanotechnology-enabled health products in bringing their products

SUBMITTER: Zabeo A 

PROVIDER: S-EPMC9089298 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature